Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $76.7700 (-3.62%) ($76.7700 - $79.1600) on Thu. May. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.53% (three month average) | RSI | 53 | Latest Price | $76.7700(-3.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(51%) IWM(50%) XAR(49%) IWO(48%) XBI(48%) | Factors Impacting LGND price | LGND will decline at least -1.265% in a week (0% probabilities). VXX(-19%) UUP(-14%) VIXM(-12%) TBT(-8%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.265% (StdDev 2.53%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $77.03 | 5 Day Moving Average | $77.29(-0.67%) | 10 Day Moving Average | $77.56(-1.02%) | 20 Day Moving Average | $77.03(-0.34%) | To recent high | -3.6% | To recent low | 14% | Market Cap | $1.234b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |